Cowealth Medical China Co (SHSE:603122) 3-Year EBITDA Growth Rate : -18.70% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cowealth Medical China Co 3-Year EBITDA Growth Rate?

Cowealth Medical China Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.03.

During the past 12 months, Cowealth Medical China Co's average EBITDA Per Share Growth Rate was -30.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cowealth Medical China Co was -8.80% per year. The lowest was -18.70% per year. And the median was -13.75% per year.

Competitive Comparison of Cowealth Medical China Co's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Cowealth Medical China Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cowealth Medical China Co's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cowealth Medical China Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cowealth Medical China Co's 3-Year EBITDA Growth Rate falls into.

Cowealth Medical China Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cowealth Medical China Co (SHSE:603122) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cowealth Medical China Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cowealth Medical China Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cowealth Medical China Co (SHSE:603122) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cowealth Medical China Co Ltd (SHSE:603122) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1001 Qinzhou North Road, 21st Floor, Building 12, Xuhui District, Shanghai, CHN, 200131

Website

https://www.cowealth.com

Cowealth Medical China Co Ltd operates as a diagnostic clinical laboratory company. It has introduced radiation oncology technology into the market.

Executives

Wang Qiong Zhi

Directors, senior managers

Cowealth Medical China Co (SHSE:603122) Headlines

No Headlines